AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Kefazolum Plus Ertopenum in MSSA Bacteremia
The success of Kefazolum plus Ertopenum in MSSA Bacteremia based on the release of Intrulukin I beta. IL-1B stimulates neutrophil recruitment and enhances your appearance of MSSA from that. The antibiotic is not acting at a level of engaging with the bacteria, it's acting at a new modulator for the host.